Lexicon Pharmaceuticals
LXRX
#6215
Rank
C$1.46 B
Marketcap
C$3.29
Share price
-0.85%
Change (1 day)
163.14%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): C-$0.27

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.27. In 2024 the company made an earnings per share (EPS) of C-$0.91 an increase over its 2023 EPS that were of C-$1.13.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.27-70.03%
2024C-$0.91-20%
2023C-$1.1331.15%
2022C-$0.86-0%
2021C-$0.8610.91%
2020C-$0.78-145.08%
2019C$1.73-206.09%
2018C-$1.63-5.74%
2017C-$1.73-10.95%
2016C-$1.942640%
2015C-$0.07089-96.34%
2014C-$1.93-2.53%
2013C-$1.98-9.09%
2012C-$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$25.83-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.84-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$60.30-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.66 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$8.93-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.71 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.06 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.98-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$108.76 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA